SCHEMBL31115435

SCHEMBL31115435

COC(=O)c1cc(Br)c2c(c1N)CCO2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ POLB P06746 1/20 0.39
▸ ACHE P22303 3/20 0.38
▸ HTR4 Q13639 2/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HTR3A P46098 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ GAA P10253 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28947251 1.00 KDM4E (0.44) KDM4EALDH1A1POLBACHEHTR4
SCHEMBL31417732 0.89 KDM4E (0.44) KDM4EALDH1A1POLBACHEHTR4
SCHEMBL23698351 0.84 KDM4E (0.39) KDM4EALDH1A1POLBGAAMAPT
SCHEMBL30678550 0.84 KDM4E (0.39) KDM4EALDH1A1POLBGAAMAPT
SCHEMBL31258473 0.83 KDM4E (0.44) KDM4EALDH1A1POLBACHEHTR4
SCHEMBL23698910 0.83 KDM4E (0.38) KDM4EALDH1A1POLBHPGDHSD17B10
SCHEMBL30639963 0.83 KDM4E (0.44) KDM4EALDH1A1POLBACHEHTR4
SCHEMBL19126021 0.82 ALDH1A1 (0.39) KDM4EALDH1A1HTR4GAAHPGD
SCHEMBL31417692 0.81 KDM4E (0.37) KDM4EALDH1A1POLBMAPTHPGD
SCHEMBL14382462 0.81 KDM4E (0.43) KDM4EALDH1A1POLBACHEHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697994-B Fused quinazoline derivative, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-13 — — CN disclosed
Send feedback